Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer

World Journal of Surgical Oncology
Pompiliu PisoHans J Schlitt

Abstract

In selected patients with peritoneal carcinomatosis from ovarian cancer prognosis can be improved by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Between September 1995 and February 1999, 19 patients (mean age 52 years, range 30-72 years) with peritoneal carcinomatosis from primary or recurrent epithelial ovarian carcinoma were operated with the aim of complete macroscopical cytoreduction. Surgery was followed by intraoperative HIPEC. The data was analyzed retrospectively. Eleven patients had recurrent and 8 primary ovarian cancer. The median progression free interval was 18 months (range 6-36 months). Macroscopically complete cytoreduction was achieved in 9 patients. Cisplatin (n = 16) or mitoxantrone (n = 3) were used for the intraoperative chemotherapy. The median intraabdominal inflow temperature was 41.5 degrees C. Complications occurred in seven patients. Most frequent complications were anastomotic leakage (2/19) and intraabdominal abscess formation (2/19). One patient died postoperatively. The mean (+/- SD) overall survival time was 33(+/- 6) months with a 5-year survival rate of 15%. The survival was found to be influenced by the completeness of cytoreduction (44 +/- 11 vs. 25 +/- 6 mont...Continue Reading

References

Jan 1, 1995·Annals of Surgery·P H Sugarbaker
Feb 2, 2000·Langenbeck's Archives of Surgery·P H Sugarbaker
Nov 1, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·V MuzioM D'Incalci
May 25, 2001·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·P PisoJ Klempnauer
Mar 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert E BristowF J Montz
Jun 12, 2002·Current Treatment Options in Oncology·M E van der Burg
Aug 23, 2002·Current Opinion in Oncology·Emery SalomRamin Mirhashemi
Feb 1, 2003·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·A-A K TentesK Avgidou
Apr 25, 2003·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·D M KecmanovicA B Stamenkovic
Oct 11, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Vic J VerwaalFrans A N Zoetmulder
Oct 22, 2003·Surgical Oncology Clinics of North America·K H LinkL Staib
Dec 17, 2003·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·M LookP H Sugarbaker
Apr 10, 2009·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·M J PavlovD M Kecmanovic

❮ Previous
Next ❯

Citations

Jan 25, 2007·International Journal of Colorectal Disease·J O W PelzT Meyer
Dec 18, 2013·Current Treatment Options in Oncology·Ramez N EskanderRobert E Bristow
Nov 3, 2007·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·F C Muñoz-CasaresA Gómez-Portilla
May 10, 2006·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·A-A K TentesI H Nikas
Mar 8, 2014·Women's Health·Martin PölcherDennis S Chi
Jan 11, 2011·Journal of Experimental & Clinical Cancer Research : CR·Olivier FacyPablo Ortega-Deballon
Mar 18, 2016·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Karol PolomFranco Roviello
Apr 20, 2006·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·F RaspagliesiM Deraco
Jan 18, 2017·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Renee A CowanDennis S Chi
May 26, 2017·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Alvaro Arjona-Sanchez, Sebastian Rufián-Peña
Jul 6, 2018·Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen·P Horvath, A Königsrainer
Apr 7, 2016·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Véronique D'HondtGabriel Liberale
Feb 5, 2016·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Alexander HotourasPaul H Sugarbaker
Nov 13, 2007·Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen·J PfistererA du Bois
Dec 7, 2007·Annals of Surgical Oncology·B L van LeeuwenH Mahteme
Apr 22, 2005·Journal of Surgical Oncology·Trevor W ReichmanLawrence E Harrison
Aug 22, 2009·Journal of Surgical Oncology·Bijan N Moradi, Jesus Esquivel
Feb 27, 2008·World Journal of Gastroenterology : WJG·Hassan-Alaa-Hammed Al-ShammaaYutaka Yonemura
Aug 1, 2012·Expert Review of Anticancer Therapy·Eelco de Bree, C William Helm
Feb 26, 2013·Journal of Gastrointestinal Cancer·Jacopo Giuliani
Apr 12, 2016·Indian Journal of Surgical Oncology·Aditi Bhatt, Olivier Glehen
Mar 25, 2016·Cancer Control : Journal of the Moffitt Cancer Center·Rahul Rajeev, Kiran K Turaga
May 14, 2016·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·L OrgianoGiovanni Mantovani

❮ Previous
Next ❯

Methods Mentioned

BETA
dissections
hysterectomy

Software Mentioned

SPSS

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.